SCHEMBL4574133

SCHEMBL4574133

CCCC(=O)OCC(O)C1OC(=O)C(O)=C1O

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.81
HSPD1 P10809 1/20 0.81
HSPE1 P61604 1/20 0.81
TST Q16762 1/20 0.81
RECQL P46063 1/20 0.81
BLM P54132 1/20 0.81
TDP1 Q9NUW8 1/20 0.81
LMNA P02545 3/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
NLRP3 Q96P20 2/20 0.39
PPM1A P35813 2/20 0.39
TYR P14679 2/20 0.34
KDM4E B2RXH2 1/20 0.33
DUSP3 P51452 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
LPAR6 P43657 1/20 0.33
LPAR1 Q92633 1/20 0.33
LPAR4 Q99677 1/20 0.33
LPAR5 Q9H1C0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4394069 1.00 MAPT (0.81) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL4394073 1.00 MAPT (0.81) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL17548911 0.92 MAPT (0.90) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL17750096 0.91 MAPT (0.97) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL972299 0.91 MAPT (0.97) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL24511445 0.90 MAPT (1.00) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL8472638 0.90 MAPT (1.00) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL22749133 0.90 MAPT (1.00) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL22749146 0.90 MAPT (1.00) MAPTHSPD1HSPE1TSTRECQL
SCHEMBL22749131 0.90 MAPT (1.00) MAPTHSPD1HSPE1TSTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008080988-A2 CYCLOPENTANONE DERIVATIVES, METHOD OF SYNTHESIS AND USES THEREOF NEUROPHARMA, S.A. (ES) 2008-07-10 WO claimed
EP-1939192-A1 Cyclopentanone derivatives, method of synthesis and uses thereof Neuropharma S.A. (ES) 2008-07-02 EP claimed
EP-3444240-A1 BRAIN-TARGETING PRODRUG FOR AMPA RECEPTOR SYNERGIST, AND PHARMACEUTICAL APPLICATIONS Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China (CN) 2019-02-20 EP disclosed
WO-2008080988-A2 CYCLOPENTANONE DERIVATIVES, METHOD OF SYNTHESIS AND USES THEREOF NEUROPHARMA, S.A. (ES) 2008-07-10 WO disclosed
EP-1939192-A1 Cyclopentanone derivatives, method of synthesis and uses thereof Neuropharma S.A. (ES) 2008-07-02 EP disclosed